120 related articles for article (PubMed ID: 3304471)
1. A review of the prognostic role of cytogenetic, phenotypic, morphologic, and immune function characteristics in chronic lymphocytic leukemia.
Rai KR; Sawitsky A
Blood Cells; 1987; 12(2):327-38. PubMed ID: 3304471
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
Mauro FR; Gentile M; Mancini F; Giannarelli D; Guarini A; De Propriis MS; Cerretti R; Foa R
Haematologica; 2002 Jun; 87(6):602-8. PubMed ID: 12031916
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
Molica S
Haematologica; 1997; 82(6):705-9. PubMed ID: 9499672
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic leukemia and prolymphocytic leukemia: a clinicopathological reappraisal.
Melo JV; Catovsky D; Galton DA
Blood Cells; 1987; 12(2):339-53. PubMed ID: 3476167
[TBL] [Abstract][Full Text] [Related]
8. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.
Ottaggio L; Viaggi S; Zunino A; Zupo S; Rossi E; Spriano M; Abbondandolo A; Ferrarini M
Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555
[TBL] [Abstract][Full Text] [Related]
9. [Different levels of differentiation of blood leukemia cells in patients with chronic lymphoid leukemia].
Zlobina EN; Baryshnikov AIu; Morozova VT; Volkova MA; Polotskaia TM
Eksp Onkol; 1987; 9(2):21-4. PubMed ID: 3495424
[TBL] [Abstract][Full Text] [Related]
10. Quantitative monitoring of lymphoid malignancies. Application and findings in chronic lymphocytic leukemia.
Kettman JR; Smith RG; Uhr JW; Vitetta ES; Sheehan R; Ligler FS; Frenkel EP
Blood Cells; 1983; 9(1):21-33. PubMed ID: 6407550
[TBL] [Abstract][Full Text] [Related]
11. Clonal chromosome changes in stimulated lymphocytes of untreated human B-cell leukemias.
Sadamori N; Han T; Minowada J; Matsui S; Sandberg AA
Cancer Res; 1983 Jul; 43(7):3287-91. PubMed ID: 6850637
[TBL] [Abstract][Full Text] [Related]
12. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
[TBL] [Abstract][Full Text] [Related]
13. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
[TBL] [Abstract][Full Text] [Related]
14. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R
Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
[TBL] [Abstract][Full Text] [Related]
16. Possible prognostic significance of the assessment of dipeptidylpeptidase II in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia.
Klener P; Lojda Z; Háber J; Kvasnicka J
Neoplasma; 1987; 34(5):581-6. PubMed ID: 3696300
[TBL] [Abstract][Full Text] [Related]
17. Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemia.
Han T; Ozer H; Sadamori N; Emrich L; Gomez GA; Henderson ES; Bloom ML; Sandberg AA
N Engl J Med; 1984 Feb; 310(5):288-92. PubMed ID: 6690952
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte doubling time in chronic lymphocytic leukemia: an update of its prognostic significance.
Viñolas N; Reverter JC; Urbano-Ispizua A; Montserrat E; Rozman C
Blood Cells; 1987; 12(2):457-70. PubMed ID: 3620708
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia.
Brito-Babapulle V; Pittman S; Melo JV; Pomfret M; Catovsky D
Hematol Pathol; 1987; 1(1):27-33. PubMed ID: 3509770
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic aspects of B-cell chronic lymphocytic leukemia: their correlation with clinical stage and different polyclonal mitogens.
Castoldi GL; Lanza F; Cuneo A
Cancer Genet Cytogenet; 1987 May; 26(1):75-84. PubMed ID: 3493839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
